Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 4,137–4,144 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Unicycive Therapeutics Inc. Oxylanthanum Carbonate (OLC) Kidney disease PDUFA Ongoing Oral N/A
Unicycive Therapeutics Inc. Renazorb (Fosrenol bioequivalent) Hyperphosphatemia NDA Filing Ongoing Oral N/A
Unicycive Therapeutics Inc. Renazorb (Fosrenol bioequivalent) Hyperphosphatemia NDA Filing Ongoing Oral N/A
United Therapeutics Corporation TYVASO (treprostinil) - (TETON) Idiopathic Pulmonary Fibrosis Phase 3 Inhalation Respiratory
United Therapeutics Corporation Ralinepag - (ADVANCE OUTCOMES) Pulmonary Arterial Hypertension Phase 3 Oral Cardiology
United Therapeutics Corporation Tyvaso (treprostinil) - (TETON PPF) Progressive pulmonary fibrosis (PPF) Phase 3 Ongoing Inhalation Respiratory
United Therapeutics Corporation TYVASO (treprostinil) - (TETON 2) Idiopathic Pulmonary Fibrosis Phase 3 Data Released Inhalation Respiratory
United Therapeutics Corporation Unituxin - DISTINCT Small cell lung cancer Phase 2/3 Intravenous Oncology